NO164657C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner.

Info

Publication number
NO164657C
NO164657C NO861178A NO861178A NO164657C NO 164657 C NO164657 C NO 164657C NO 861178 A NO861178 A NO 861178A NO 861178 A NO861178 A NO 861178A NO 164657 C NO164657 C NO 164657C
Authority
NO
Norway
Prior art keywords
naphthyridinones
preparation
therapeutically active
analogy procedure
analogy
Prior art date
Application number
NO861178A
Other languages
English (en)
Other versions
NO861178L (no
NO164657B (no
Inventor
Margaret Hagar Sherlock
Sidney Randall Smith
Marvin Ira Siegel
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/716,003 external-priority patent/US4596809A/en
Priority claimed from US06/836,357 external-priority patent/US4687774A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO861178L publication Critical patent/NO861178L/no
Publication of NO164657B publication Critical patent/NO164657B/no
Publication of NO164657C publication Critical patent/NO164657C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO861178A 1985-03-25 1986-03-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner. NO164657C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/716,003 US4596809A (en) 1985-03-25 1985-03-25 Substituted 1,8-naphthyridinones, useful as anti-allergic agents
US06/836,357 US4687774A (en) 1986-03-10 1986-03-10 Method for suppressing the immune response

Publications (3)

Publication Number Publication Date
NO861178L NO861178L (no) 1986-09-26
NO164657B NO164657B (no) 1990-07-23
NO164657C true NO164657C (no) 1990-10-31

Family

ID=27109452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861178A NO164657C (no) 1985-03-25 1986-03-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner.

Country Status (13)

Country Link
EP (1) EP0196024B1 (no)
KR (1) KR900004829B1 (no)
AU (1) AU579718B2 (no)
DE (1) DE3675671D1 (no)
DK (1) DK127086A (no)
FI (1) FI84828C (no)
GR (1) GR860757B (no)
HU (1) HU196074B (no)
IL (1) IL78230A0 (no)
NO (1) NO164657C (no)
NZ (1) NZ215562A (no)
OA (1) OA08271A (no)
PT (1) PT82257B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054665T3 (es) * 1986-04-11 1994-08-16 Schering Corp Derivados de naftiridina y piridopirazina sustituidos con arilo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092786B1 (en) * 1982-04-26 1987-01-07 Schering Corporation 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
ES8609323A1 (es) * 1984-02-02 1986-07-16 Merck & Co Inc Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas.
ES2054665T3 (es) * 1986-04-11 1994-08-16 Schering Corp Derivados de naftiridina y piridopirazina sustituidos con arilo.

Also Published As

Publication number Publication date
HU196074B (en) 1988-09-28
FI861194A (fi) 1986-09-26
AU579718B2 (en) 1988-12-08
NZ215562A (en) 1988-11-29
FI861194A0 (fi) 1986-03-21
FI84828B (fi) 1991-10-15
EP0196024A1 (en) 1986-10-01
NO861178L (no) 1986-09-26
EP0196024B1 (en) 1990-11-22
DK127086D0 (da) 1986-03-19
OA08271A (fr) 1987-10-30
NO164657B (no) 1990-07-23
FI84828C (fi) 1992-01-27
IL78230A0 (en) 1986-07-31
KR900004829B1 (ko) 1990-07-07
PT82257A (en) 1986-04-01
KR860007263A (ko) 1986-10-10
HUT41797A (en) 1987-05-28
PT82257B (pt) 1988-07-29
DK127086A (da) 1986-09-26
AU5502786A (en) 1986-10-02
DE3675671D1 (de) 1991-01-03
GR860757B (en) 1986-07-28

Similar Documents

Publication Publication Date Title
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
NO863671L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO865148L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
NO162468C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino (4[,5[;3,4)-pyrrolo-( 2,1-a)-isokinolinderivater.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
NO164657C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner.